tiprankstipranks
Trending News
More News >

Wave Life Sciences price target lowered to $19 from $22 at B. Riley

B. Riley lowered the firm’s price target on Wave Life Sciences (WVE) to $19 from $22 and keeps a Buy rating on the shares. The firm cites FDA timeline risk for the target cut, which it notes is not unique to Wave Life.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1